[Importance of the cefotaxime-fosfomycin combination. Apropos of a case of meningitis due to heterogeneously resistant Staphylococcus aureus].
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D002439:Cefotaxime
Intérêt de l'association cefotaxime-fosfomycine. A propos d'un cas de méningite à staphylocoque doré résistant hétérogène.